Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome

被引：3

作者：

Unterluggauer, Julia J. ^{[1
]}

Prochazka, Katharina ^{[2
]}

Tomazic, Peter V. ^{[3
]}

Huber, Heinrich J. ^{[4
]}

Seeboeck, Rita ^{[5
]}

Fechter, Karoline ^{[2
]}

Steinbauer, Elisabeth ^{[1
]}

Gruber, Verena ^{[1
]}

Feichtinger, Julia ^{[6
,7
]}

Pichler, Martin ^{[8
]}

Weniger, Marc A. ^{[9
]}

Kueppers, Ralf ^{[9
,10
]}

Sill, Heinz ^{[2
]}

Schicho, Rudolf ^{[11
]}

Neumeister, Peter ^{[2
]}

Beham-Schmid, Christine ^{[1
]}

Deutsch, Alexander J. A. ^{[2
]}

Haybaeck, Johannes ^{[1
,12
]}

机构：

[1] Med Univ Graz, Diagnost & Res Inst Pathol, Diagnost & Res Ctr Mol BioMed, Graz, Austria

[2] Med Univ Graz, Div Hematol, Graz, Austria

[3] Med Univ Graz, Dept Otorhinolaryngol, Graz, Austria

[4] Otto von Guericke Univ, Inst Automat Engn, Magdeburg, Germany

[5] IMC Univ Appl Sci Krems, Dept Life Sci, Krems, Austria

[6] Graz Univ Technol, Inst Computat Biotechnol, Graz, Austria

[7] BioTechMed Omics Ctr Graz, Graz, Austria

[8] Med Univ Graz, Dept Internal Med, Graz, Austria

[9] Univ Duisburg Essen, Inst Cell Biol Canc Res, Essen, Germany

[10] German Canc Consortium DKTK, Heidelberg, Germany

[11] Med Univ Graz, Otto Loewi Res Ctr, Div Pharmacol, Graz, Austria

[12] Otto von Guericke Univ, Fac Med, Dept Pathol, Magdeburg, Germany

来源：

BLOOD CANCER JOURNAL | 2018年 / 8卷

基金：

奥地利科学基金会;

关键词：

BINDING-PROTEIN; 4E;

D O I：

10.1038/s41408-018-0112-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：5

共 50 条

[1] Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome
Julia J. Unterluggauer
Katharina Prochazka
Peter V. Tomazic
Heinrich J. Huber
Rita Seeboeck
Karoline Fechter
Elisabeth Steinbauer
Verena Gruber
Julia Feichtinger
Martin Pichler
Marc A. Weniger
Ralf Küppers
Heinz Sill
Rudolf Schicho
Peter Neumeister
Christine Beham-Schmid
Alexander J. A. Deutsch
Johannes Haybaeck
Blood Cancer Journal, 8
[2] DC-SCRIPT Expression in Diffuse Large B-Cell Lymphoma with Clinical Correlation
Li, L.
Laziuk, K.
Sheehan, C.
Nazeer, T.
LABORATORY INVESTIGATION, 2012, 92 : 351A - 351A
[3] ARD1 Expression in Diffuse Large B-Cell Lymphoma with Clinical Correlation
Li, L.
Laziuk, K.
Sheehan, C.
Nazeer, T.
LABORATORY INVESTIGATION, 2012, 92 : 351A - 351A
[4] ARD1 Expression in Diffuse Large B-Cell Lymphoma with Clinical Correlation
Li, L.
Laziuk, K.
Sheehan, C.
Nazeer, T.
MODERN PATHOLOGY, 2012, 25 : 351A - 351A
[5] DC-SCRIPT Expression in Diffuse Large B-Cell Lymphoma with Clinical Correlation
Li, L.
Laziuk, K.
Sheehan, C.
Nazeer, T.
MODERN PATHOLOGY, 2012, 25 : 351A - 351A
[6] Expression of Histone Deacetylases in Diffuse Large B-cell Lymphoma and Its Clinical Significance
Lee, Sung Hak
Yoo, Changyoung
Im, Soyoung
Jung, Ji-Han
Choi, Hyun Joo
Yoo, Jinyoung
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2014, 11 (10): : 994 - 1000
[7] MicroRNA-155 expression and outcome in diffuse large B-cell lymphoma
Jung, Inkyung
Aguiar, Ricardo C. T.
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 144 (01) : 138 - 140
[8] Lymphoma Recurrence 5 Years or Later Following Diffuse Large B-Cell Lymphoma: Clinical Characteristics and Outcome
Larouche, Jean-Francois
Berger, Francoise
Chassagne-Clement, Catherine
Ffrench, Martine
Callet-Bauchu, Evelyne
Sebban, Catherine
Ghesquieres, Herve
Broussais-Guillaumot, Florence
Salles, Gilles
Coiffier, Bertrand
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (12) : 2094 - 2100
[9] Lymphoma recurrence 5 years or more following diffuse large B-cell lymphoma: Clinical characteristics and outcome
Larouche, J.
Berger, F.
Chassagne-Clement, C.
Sebban, C.
Ghesquieres, H.
Salles, G.
Coiffier, B.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[10] Bcl-2 gene expression as a predictor of outcome in diffuse large B-cell lymphoma
Shivakumar, Latha
Armitage, James O.
CLINICAL LYMPHOMA & MYELOMA, 2006, 6 (06): : 455 - 457

← 1 2 3 4 5 →